SHEILA AGIM: Open Payments
NPI 1508516949 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 13 payments from 9 companies in 2025. Trend: 2023 $122 · 2024 $219 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $107 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Madrigal Pharmaceuticals | 1 | $41 |
| Lilly USA, LLC | 2 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| PFIZER INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
Products named: REZDIFFRA, JARDIANCE, JOURNAVX, Ozempic, PREVNAR 20, BREZTRI, LAGEVRIO, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
